T3D Therapeutics, Inc.
- Raised $6 million (2022)
- 3 clinical trials, 1 active
- Research grants: $11 million
- Founded 2013
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Tempo Therapeutics, Inc.
- Raised $16 million (2024)
- 1 clinical trial
- Research grants: $10 million
Bio-Rad Laboratories, Inc.
NYSE: BIO
- 2 clinical trials
- FDA-cleared or approved devices
Cooler Heads Care, Inc.
- Raised $11 million (2025)
- FDA-cleared or approved devices
- Research grants: $4.6 million
- Founded 2018
Deep Blue Medical Advances, Inc.
- Raised $5.3 million (2025)
- FDA-cleared or approved devices
- Research grants: $7.3 million
- Founded 2015
Minnetronix Medical, Inc.
- 2 clinical trials
- 1 FDA-registered device site
- Research grants: $24 million
Voximetry, Inc.
- Raised $4.6 million (2023)
- FDA-cleared or approved devices
- Research grants: $17 million
- Founded 2021
Syndax Pharmaceuticals Inc
Nasdaq: SNDX
- Raised $61 million (2015)
- 30 clinical trials, 5 active
- Founded 2005
TransMedics, Inc.
- Raised $64 million (2016)
- 26 clinical trials, 10 active
- FDA-cleared or approved devices
Spectrum Pharmaceuticals Inc
- Raised $3 million (2016)
- 63 clinical trials, 1 active
- 3 FDA-registered drug sites
Ardelyx, Inc.
Nasdaq: ARDX
- Raised $110 million (2016)
- 29 clinical trials, 2 active
- Founded 2007
Meissa Vaccines Inc
- Raised $14 million (2019)
- 5 clinical trials
- Research grants: $3.6 million
- Founded 2014
Neotract Inc
- Raised $13 million (2017)
- 9 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2004
Pear Therapeutics, Inc.
- Raised $132 million (2021)
- 3 clinical trials
- Research grants: $2.9 million
- Founded 2013
Rhythm Pharmaceuticals, Inc.
Nasdaq: RYTM
- Raised $20 million (2017)
- 29 clinical trials, 5 active
- Founded 2008
Beam Therapeutics Inc.
Nasdaq: BEAM
- Raised $84 million (2019)
- 6 clinical trials, 6 active
- Founded 2017
Cocrystal Pharma, Inc.
Nasdaq: COCP
- Raised $3 million (2017)
- 6 clinical trials, 1 active
- Research grants: $498,199
Forte Biosciences, Inc.
Nasdaq: FBRX
- Raised $25 million (2023)
- 6 clinical trials, 4 active
- Founded 2007
inSoma Bio, Inc.
- Raised $2.7 million (2026)
- 1 clinical trial
- Research grants: $6.8 million
- Founded 2018
MapLight Therapeutics, Inc.
Nasdaq: MPLT
- Raised $188 million (2025)
- 6 clinical trials, 4 active
- Founded 2018
Mineralys Therapeutics, Inc.
Nasdaq: MLYS
- Raised $118 million (2022)
- 6 clinical trials, 1 active
- Founded 2019
Nuvalent, Inc.
Nasdaq: NUVL
- Raised $135 million (2021)
- 6 clinical trials, 4 active
- Founded 2017
SpyGlass Pharma, Inc.
Nasdaq: SGP
- Raised $75 million (2025)
- 6 clinical trials, 5 active
- Founded 2019
Tango Therapeutics, Inc.
Nasdaq: TNGX
- Raised $15 million (2025)
- 7 clinical trials, 5 active
- Founded 2020
Vera Therapeutics, Inc.
Nasdaq: VERA
- Raised $71 million (2021)
- 6 clinical trials, 4 active
- Founded 2016
Verastem, Inc.
Nasdaq: VSTM
- Raised $100 million (2020)
- 27 clinical trials, 10 active
- Founded 2010
Viridian Therapeutics, Inc.\DE
Nasdaq: VRDN
- Raised $91 million (2020)
- 6 clinical trials
- Founded 2006
Whitehawk Therapeutics, Inc.
Nasdaq: WHWK
- Raised $100 million (2025)
- 14 clinical trials, 5 active
Enalare Therapeutics Inc.
- Raised $13 million (2022)
- 2 clinical trials, 1 active
- Research grants: $5.6 million
- Founded 2018
Transonic Systems, Inc.
- 17 clinical trials
- FDA-cleared or approved devices
- Research grants: $13 million
Angiodynamics Inc
Nasdaq: ANGO
- 22 clinical trials, 10 active
- FDA-cleared or approved devices
MDI Therapeutics, Inc.
- Raised $1.7 million (2022)
- 2 clinical trials
- Research grants: $7.3 million
- Founded 2022
Fate Therapeutics Inc
Nasdaq: FATE
- Raised $50 million (2020)
- 25 clinical trials, 6 active
- Founded 2007
Paratek Pharmaceuticals, Inc.
- Raised $93 million (2014)
- 14 clinical trials, 1 active
- Research grants: $3.8 million
Adma Biologics, Inc.
Nasdaq: ADMA
- Private funding (2013)
- 7 clinical trials
- 1 FDA-registered drug site
Neogen Corp
Nasdaq: NEOG
- FDA-cleared or approved devices
- 1 FDA-registered drug site
- Research grants: $38,554
Arrowhead Pharmaceuticals, Inc.
Nasdaq: ARWR
- Raised $64 million (2013)
- 51 clinical trials, 14 active
INSMED Inc
Nasdaq: INSM
- Raised $84 million (2010)
- 49 clinical trials, 7 active
Elysium Therapeutics, Inc.
- Raised $2.2 million (2022)
- 1 clinical trial
- Research grants: $10 million
- Founded 2013
Flugen Inc
- Raised $8.2 million (2020)
- 6 clinical trials
- Research grants: $9.8 million
- Founded 2007
Adient Medical, Inc.
- Raised $14 million (2022)
- 1 clinical trial, 1 active
- Research grants: $8.4 million
- Founded 2012
ArriVent BioPharma, Inc.
Nasdaq: AVBP
- Raised $110 million (2022)
- 6 clinical trials, 6 active
- Founded 2021
Basking Biosciences, Inc.
- Raised $55 million (2025)
- 3 clinical trials, 1 active
- Research grants: $4.5 million
- Founded 2019
CASI Pharmaceuticals, Inc.
OTC: CASIF
- Raised $5 million (2026)
- 23 clinical trials, 2 active
- Founded 2023
Celcuity Inc.
Nasdaq: CELC
- Raised $130 million (2025)
- 5 clinical trials, 3 active
- Founded 2011
Cerenome, Inc.
Nasdaq: CNSY
- Raised $300,000 (2020)
- 5 clinical trials, 5 active
- Research grants: $249,877
Clarametyx Biosciences, Inc.
- Raised $28 million (2024)
- 2 clinical trials
- Research grants: $6.3 million
- Founded 2020
CONMED Corp
NYSE: CNMD
- 2 clinical trials, 2 active
- FDA-cleared or approved devices
Contraline, Inc.
- Raised $56 million (2026)
- 1 clinical trial
- Research grants: $3.6 million
- Founded 2017
Janux Therapeutics, Inc.
Nasdaq: JANX
- Raised $125 million (2021)
- 5 clinical trials, 5 active
- Founded 2017
Published company profiles only; counts update daily. Data licences